Trastuzumab-PEG8-DBCO

Trastuzumab-PEG8-DBCO is an Anti-Her2 human monoclonal antibody (Trastuzumab) stochastic conjugated NHS-PEG8-DBCO with the lysine residences of the antibody. The DAR of Trastuzumab-PEG8-DBCO is 3 ~ 5. >98% of antibody is conjugated. This DBCO functionalized antibody can be used as a scaffolding to conjugation with any payloads contain azido group by one-step click chemistry. This product is for research use only.

Product Details
Species Reactivity	Human
Host/Isotype	Cell culture/ IgG1
Class	Monoclonal
Type	Antibody-Linker conjugate
Immunogen	Human Her2
DAR (Drug to Antibody Ratio)	3 ~ 5
Clone	Trastuzumab biosimilar
Conjugate	Trastuzumab conjugated with NHS-PEG8-DBCO
Purity	>98%
Molecular Weight	~150kDa
Protein Concentration	2 mg/ml
Storage Condition	4°C for short time, -20°C or -80°C for long time.
Storage Buffer	PBS buffer pH7.4